Overview
- 18 inspections across 17 sites are on record.
- 86 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-07-17.
At a glance
Inspections
18
Sites
17
Observations
86
Career since
Dec 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Istituto Biochimico Italiano Giovanni Lorenzini | 17 Jul 2018 | Human Drugs | View 483 → |
| Bioreliance Ltd. | 22 Sep 2017 | Human Drugs | On file |
| NAMSA | 15 Sep 2017 | Human Drugs | On file |
| Novartis Pharma S.A.S. - Centre de Biotechnologie | 12 Sep 2017 | Human Drugs | On file |
| BAV Institut fr Hygiene und Qualittssicherung GmbH | 3 Nov 2016 | Human Drugs |
Sites inspected
Istituto Biochimico Italiano Giovanni LorenziniAprilia, Italy1 insp.
Bioreliance Ltd.Glasgow, United Kingdom1 insp.
NAMSAChasse Sur Rhone, France1 insp.
Novartis Pharma S.A.S. - Centre de BiotechnologieHuningue, France1 insp.
BAV Institut fr Hygiene und Qualittssicherung GmbHOffenburg, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Satheesh Thomas4 shared
Carla J Lundi3 shared
Frank J Marciniak3 shared
Linda F Murphy2 shared
Ademola O Daramola2 shared
Justin A Boyd2 shared
Erik W Koester1 shared
Dhaval H Patel1 shared
Charisse K Green1 shared
Full investigator report
Get the verbatim findings behind Xiaoping Guan's 86 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site